Basic Information
Basic information for CCDC26-217-16aa
Peptide Name CCDC26-217-16aa
Genome Position chr8:129352799-129352846[-]
Species Human
Peptide Sequence MSSSIGIIIHISFLFC
Peptide Length 16
Unique No (CCDC26-201-16aa,CCDC26-205-16aa,CCDC26-228-16aa,CCDC26-231-16aa,CCDC26-233-16aa-2,CCDC26-236-16aa,CCDC26-237-16aa,CCDC26-245-16aa,CCDC26-246-16aa,CCDC26-247-16aa-1,CCDC26-254-16aa,CCDC26-262-16aa,CCDC26-263-16aa-2,CCDC26-264-16aa,CCDC26-268-16aa,CCDC26-277-16aa,CCDC26-280-16aa)
Grand Average of Hydropathicity 1.8438
Relative Molecular Mass 2038.36
Experimental Evidences 1:m6A
lncRNA ID/Name ENSG00000229140;CCDC26
Transcript ID/Name ENST00000652971;CCDC26-217
Transcript Length 1636
Coding Ability 0.2017
DNA Sequence Corresponding to Peptide ATGTCTTCATCTATTGGAATAATTATACATATCTCTTTTTTATTCTGT
Experimental Evidences
   m6A
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :